CPhI preview – Dr Reddy’s CPS provides customised services and solutions

Expertise and capabilities in pharmaceutical development and manufacturing for starting materials, intermediates, active ingredients and finished dosage forms

Dr Reddy’s CPS (Custom Pharma Services), as a strategic business unit of Dr. Reddy’s, draws on our company’s expertise and capabilities in pharmaceutical development and manufacturing to provide innovators with customised services and solutions for starting materials, intermediates, active ingredients and finished dosage forms.

CPS added value offerings:

  • API and intermediate development and cGMP manufacture
  • Latest innovations in analysis, QbD, continuous and Green Chemistry
  • Chiral synthesis using both chemo and biocatalytic approaches
  • HPAI, cytotoxic, steroid and prostaglandin capabilities
  • Complex carbohydrates, activated PEG and peptides
  • Solid state technologies, formulation development and manufacture

Drug substance: CPS has state-of-the-art synthetic organic chemistry laboratories located across the globe with 300+ chemists and engineers to serve the needs of drug development and manufacture.

Drug product: CPS’s strong capabilities in oral solid dosage forms, combination products, high potent dosage forms (orals and injectables) and niche technologies make us an excellent partner of choice for our innovators development and manufacturing needs.

For further information please contact:

Dr. Reddy's Laboratories (SA) Ltd

Elisabethenanlage 11, CH-4051 Basel, Switzerland

T +41 61 271 4754

F +41 61 271 4755

andyevans@drreddys.com

www.drreddys-cps.com

Hall 4 Stand D05

Companies